Target intelligence / Profile preview

Pathogenic microbe or virus

Molecular classification
Other
01

Overview

The term "pathogenic microbe or virus" refers broadly to any microorganism—bacterium, virus, fungus, or protozoan—capable of causing disease in its host. These agents are highly diverse in their molecular structure, replication strategies, and pathogenic mechanisms[4]. They universally modulate or evade the host immune system, establishing infection through molecular interactions with host cells while often evolving resistance to therapeutic agents, especially with the emergence of multidrug-resistant strains[3][2]. Clinical control of pathogenic microbes and viruses is a major global health challenge, with approaches including antibiotics, antivirals, antifungals, phage therapy, and newer modalities like CRISPR-based antimicrobials[2][3][1]. While highly relevant in the context of infectious diseases, this term is not a single, specific molecular target but instead encompasses a vast set of unrelated molecular entities unified only by their ability to cause disease. Note: - This entry is incorrect as a drug target: "Pathogenic microbe/virus" is a category of disease-causing organisms, not a single, specific molecular entity suitable for molecule-level targeting or structural annotation[3][4]. Thus, it does not correspond to a canonical molecular target as typically defined in drug discovery.

Other names
Pathogenic microorganismDisease-causing microbeInfectious pathogenPathogen
02

Mechanism of action

Inhibition of cell wall synthesis; Inhibition of protein synthesis; Inhibition of nucleic acid synthesis; Disruption of membrane integrity; Protease inhibition (for some viruses); Immune modulation; Direct pathogen lysis (e.g., phage therapy)[2][3][4][1]

03

Biological functions

InfectionImmune system evasionPathogenesisTransmissionModulation of host response
04

Disease associations

InfectionInflammationImmune system disordersCancer (in some cases, e.g., oncogenic viruses)
05

Safety considerations

Antimicrobial resistanceOff-target toxicity (damage to commensal microbiota or host tissues)Secondary infections and superinfectionsImmune-mediated adverse effects (e.g., cytokine release)[1][2][3][4]
06

Interacting drugs

Antibiotics (e.g., beta-lactams, macrolides, quinolones)

4 more in the full profile.

07

Biomarkers

Pathogen-specific nucleic acids (e.g., PCR for viral RNA/DNA)Antigen detection (e.g., rapid antigen tests)Host response markers (e.g., CRP, procalcitonin)Serology (antibodies to specific pathogens)[3][4][5]

Beyond the preview

Go deeper on Pathogenic microbe or virus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic microbe or virus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call